ARID1A and endometrial endometrioid adenocarcinoma: Expression of ARID1A in ARID1A-deficient uterine endometrioid carcinoma cell lines reduced cellular proliferation, the percentage of cells in the S phase, and the growth of tumour xenografts [13].